Spineguard (XPAR:ALSGD) Unearned Premiums

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XPAR:ALSGD Spineguard XPAR:ALSGD
41 GF Score
Price €0.11
GF Value €0.08
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Spineguard Unearned Premiums?

Unearned Premiums only applies to insurance companies.

XPAR:ALSGD
41GF Score
Spineguard XPAR:ALSGD
Unearned Premiums is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Spineguard (XPAR:ALSGD) Overvalued in 2026?

Based on GuruFocus' analysis, Spineguard stock appears to be overvalued. The current stock price of €0.11 is trading 37.3% above its estimated GF Value™ of €0.08. GuruFocus considers Spineguard to be Significantly Overvalued.

Key valuation signals for XPAR:ALSGD:

  • Unearned Premiums:
  • GF Value™: €0.08 vs. price of €0.11 (37.3% above fair value)
  • GF Score™: 41/100 with 4 warning signs

No single metric tells the full story. See the XPAR:ALSGD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Spineguard Business Description

Other Exchanges 6W5:Germany
Address 10 Cours Louis Lumiere, Vincennes, FRA, 94300
Spineguard is engaged in the design and production of medical instruments used for spinal surgeries. It is deploying its proprietary radiation-free real time sensing technology DSG (Dynamic Surgical Guidance) to secure and streamline the placement of implants in the skeleton. It designs, develops and markets medical devices embedding its technology. The group is developing DSG digital technology for real-time surgical guidance without X-rays to improve the safety and simplify the placement of bone implants, pedicle screws, and smart drills. SpineGuard is extending the applications of its DSG technology to anterior scoliosis treatment, sacroiliac joint fusion, and dental implantology.
41GF Score

Get the complete analysis for XPAR:ALSGD

Unearned Premiums is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.11
Price
€0.08
GF Value